Decision-Tree Models Indicative of Microvascular Invasion on MRI Predict Survival in Patients with Hepatocellular Carcinoma Following Tumor Ablation

References

• Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208–1236.
   PubMed Web of Science ®Google Scholar
• Yau T, Tang VY, Yao TJ, Fan ST, Lo CM, Poon RT. Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma. Gastroenterology. 2014;146(7):1691–1700.e1693.
   PubMed Web of Science ®Google Scholar
• Schnapauff D, Tegel BR, Powerski MJ, Colletini F, Hamm B, Gebauer B. Interstitial Brachytherapy in Combination With Previous Transarterial Embolization in Patients With Unresectable Hepatocellular Carcinoma. Anticancer Res. 2019;39(3):1329–1336.
   PubMed Web of Science ®Google Scholar
• Collettini F, Singh A, Schnapauff D, et al. Computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of metastases adjacent to the liver hilum. Eur J Radiol. 2013;82(10):e509–514.
   PubMed Web of Science ®Google Scholar
• Schnapauff D, Collettini F, Hartwig K, et al. CT-guided brachytherapy as salvage therapy for intrahepatic recurrence of HCC after surgical resection. Anticancer Res. 2015;35(1):319–323.
   PubMed Web of Science ®Google Scholar
• Collettini F, Schnapauff D, Poellinger A, et al. Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5-7 cm) and very large (>7 cm) tumours. Eur Radiol. 2012;22(5):1101–1109.
   PubMed Web of Science ®Google Scholar
• Zuo TY, Liu FY, Wang MQ, Chen XX. Transcatheter Arterial Chemoembolization Combined with Simultaneous Computed Tomography-guided Radiofrequency Ablation for Large Hepatocellular Carcinomas. Chin Med J. 2017;130(22):2666–2673.
   PubMed Web of Science ®Google Scholar
• Jeng KS, Chang CF, Jeng WJ, Sheen IS, Jeng CJ. Heterogeneity of hepatocellular carcinoma contributes to cancer progression. Crit Rev Oncol Hematol. 2015;94(3):337–347.
   PubMed Web of Science ®Google Scholar
• Zheng Z, Guan R, Jianxi W, et al. Microvascular Invasion in Hepatocellular Carcinoma: a Review of Its Definition, Clinical Significance, and Comprehensive Management. J Oncol. 2022;2022:9567041.
   PubMedGoogle Scholar
• Lim KC, Chow PK, Allen JC, et al. Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria. Ann Surg. 2011;254(1):108–113.
   PubMed Web of Science ®Google Scholar
• Chen X, Cheung ST, So S, et al. Gene expression patterns in human liver cancers. Mol Biol Cell. 2002;13(6):1929–1939.
   PubMed Web of Science ®Google Scholar
• Segal E, Sirlin CB, Ooi C, et al. Decoding global gene expression programs in liver cancer by noninvasive imaging. Nat Biotechnol. 2007;25(6):675–680.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Wang DS, Kim HJ, et al. A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma. Hepatology. 2015;62(3):792–800.
   PubMed Web of Science ®Google Scholar
• Renzulli M, Brocchi S, Cucchetti A, et al. Can Current Preoperative Imaging Be Used to Detect Microvascular Invasion of Hepatocellular Carcinoma? Radiology. 2016;279(2):432–442.
   PubMed Web of Science ®Google Scholar
• Li X, Zhang X, Li Z, et al. Two-Trait Predictor of Venous Invasion on Contrast-Enhanced CT as a Preoperative Predictor of Outcomes for Early-Stage Hepatocellular Carcinoma After Hepatectomy. Front Oncol. 2021;11:688087.
   PubMed Web of Science ®Google Scholar
• Bakr S, Gevaert O, Patel B, et al. Interreader Variability in Semantic Annotation of Microvascular Invasion in Hepatocellular Carcinoma on Contrast-enhanced Triphasic CT Images. Radiol Imaging Cancer. 2020;2(3):e190062.
   PubMedGoogle Scholar
• American College of Radiology Committee on LI-RADS®. LI-RADS Assessment Categories 2018. Available from: https://www.acr.org/-/media/ACR/Files/RADS/LI-RADS/Translations/LI-RADS-2018-CT-MRI-Core-German.pdf. Accessed June 5, 2024.
   Google Scholar
• National Cancer Institute. The Cancer Genome Atlas - Liver Hepatocellular Carcinoma (TCGA-LIHC) database. Available from: https://portal.gdc.cancer.gov/projects/TCGA-LIHC. Accessed June 5, 2024.
   Google Scholar
• Ricke J, Wust P, Stohlmann A, et al. CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: Phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys. 2004;58(5):1496–1505.
   PubMed Web of Science ®Google Scholar
• Bretschneider T, Ricke J, Gebauer B, Streitparth F. Image-guided high-dose-rate brachytherapy of malignancies in various inner organs - technique, indications, and perspectives. J Contemp Brachytherapy. 2016;8(3):251–261.
   PubMed Web of Science ®Google Scholar
• Mohnike K, Wieners G, Schwartz F, et al. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival. Int J Radiat Oncol Biol Phys. 2010;78(1):172–179.
   PubMed Web of Science ®Google Scholar
• Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30(1):52–60.
   PubMed Web of Science ®Google Scholar
• Mariotto AB, Noone AM, Howlader N, et al. Cancer survival: an overview of measures, uses, and interpretation. J Natl Cancer Inst Monogr. 2014;2014(49):145–186.
   PubMedGoogle Scholar
• Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology. 2014;273(1):241–260.
   PubMed Web of Science ®Google Scholar
• Xu H, Schmidt R, Hamm CA, et al. Comparison of intrahepatic progression patterns of hepatocellular carcinoma and colorectal liver metastases following CT-guided high dose-rate brachytherapy. Ther Adv Med Oncol. 2021;13:17588359211042304.
   Web of Science ®Google Scholar
• Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329–338.
   PubMed Web of Science ®Google Scholar
• Galle PR. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236.
   PubMed Web of Science ®Google Scholar
• Cunha GM, Sirlin CB, Fowler KJ. Imaging diagnosis of hepatocellular carcinoma: LI-RADS. Chin Clin Oncol. 2021;10(1):3.
   PubMed Web of Science ®Google Scholar
• Lencioni R, Crocetti L. Local-regional treatment of hepatocellular carcinoma. Radiology. 2012;262(1):43–58.
   PubMed Web of Science ®Google Scholar
• Iezzi R, Pompili M, Posa A, Coppola G, Gasbarrini A, Bonomo L. Combined locoregional treatment of patients with hepatocellular carcinoma: state of the art. World J Gastroenterol. 2016;22(6):1935–1942.
   PubMed Web of Science ®Google Scholar
• An C, Kim MJ. Imaging features related with prognosis of hepatocellular carcinoma. Abdom Radiol. 2019;44(2):509–516.
   PubMed Web of Science ®Google Scholar
• Khatri G, Merrick L, Miller FH. MR imaging of hepatocellular carcinoma. Magn Reson Imaging Clin N Am. 2010;18(3):421–450, x.
   PubMed Web of Science ®Google Scholar
• Cho E-S, Choi J-Y. MRI Features of Hepatocellular Carcinoma Related to Biologic Behavior. Korean J Radiol. 2015;16(3):449.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Perálvarez M, Luong TV, Andreana L, Meyer T, Dhillon AP, Burroughs AK. A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability. Ann Surg Oncol. 2013;20(1):325–339.
   PubMed Web of Science ®Google Scholar
• Pawlik TM, Gleisner AL, Anders RA, Assumpcao L, Maley W, Choti MA. Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility. Ann Surg. 2007;245(3):435–442.
   PubMed Web of Science ®Google Scholar
• Wang JH, Li XS, Tang HS, et al. Vessels that encapsulate tumor clusters (VETC) pattern predicts the efficacy of adjuvant TACE in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2023;149(8):4163–4172.
   PubMed Web of Science ®Google Scholar
• Tang H, Bai HX, Su C, Lee AM, Yang L. The effect of cirrhosis on radiogenomic biomarker’s ability to predict microvascular invasion and outcome in hepatocellular carcinoma. Hepatology. 2016;64(2):691–692.
   PubMed Web of Science ®Google Scholar
• Imai K, Yamashita YI, Yusa T, et al. Microvascular Invasion in Small-sized Hepatocellular Carcinoma: significance for Outcomes Following Hepatectomy and Radiofrequency Ablation. Anticancer Res. 2018;38(2):1053–1060.
   PubMed Web of Science ®Google Scholar
• Chen ZH, Zhang XP, Zhou TF, et al. Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: a systematic review and meta-analysis. Eur J Surg Oncol. 2019;45(11):2188–2196.
   PubMed Web of Science ®Google Scholar
• Yang Y, Lin K, Liu L, et al. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: a propensity score matching analysis. Cancer Med. 2021;10(6):2100–2111.
   PubMed Web of Science ®Google Scholar
• Zhang T, Pandey G, Xu L, et al. The Value of TTPVI in Prediction of Microvascular Invasion in Hepatocellular Carcinoma. Cancer Manag Res. 2020;12:4097–4105.
   PubMed Web of Science ®Google Scholar
• Xu W, Wang Y, Yang Z, Li J, Li R, Liu F. New Insights Into a Classification-Based Microvascular Invasion Prediction Model in Hepatocellular Carcinoma: a Multicenter Study. Front Oncol. 2022;12:796311.
   PubMed Web of Science ®Google Scholar
• Vogel A, Cervantes A, Chau I, et al. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):548.
   Google Scholar